University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
The purpose of this study is to obtain new knowledge regarding screening for COPD. This study will use a participant's cancer screening CT scans performed as part of routine health care among current and former smokers at risk for COPD to identify participants who have had a spirometry or will have a spirometry test as part of the study to verify COPD status.
• Eligible for lung cancer screening by USPSTF 2021 criteria including age 50-80 years and currently or formerly smoking with at last 20 pack-years of smoking history at the time of consent.
• Willingness to participate in an observational clinical trial and to be contacted about future ancillary studies that could include interventional clinical trials.
• Ability to tolerate study procedures.
• Ability to provide informed consent.
• Clinical Lung Cancer Screening CT performed at the University of Michigan within the last year
• Meets one of the three following criteria:
‣ Prior Diagnosis of COPD in the EMR
⁃ Prior pulmonary function meeting criteria for COPD (FEV1/FVC ≤ 0.70) or
⁃ LAA\>1% on lung cancer screening CT scan